Beratungsaufträgen im Bereich der Unternehmensfinanzierung

Bsp. von Beratungsaufträgen

Unter Beachtung der Vertraulichkeit unserer Auftraggeber kommunizieren wir keine Kundenreferenzen :

Unternehmensbewertung – Medizintechnologie
LJ Advisory führte eine finanzielle Bewertung durch und erstellte ein Term Sheet für eine Kapitalerhöhung eines Medizintechnologieunternehmens in Frankreich.
Unternehmensbewertung – Biotechnologie
LJ Advisory führte eine Finanzbewertung durch und erstellte ein Term Sheet für eine Kapitalerhöhung eines Biotechnologieunternehmens in der Schweiz.
Unternehmensbewertung – Medizintechnologie
Für ein Medizintechnologieunternehmen in Frankreich hat LJ Advisory Entwicklungsszenarien erarbeitet, den Finanzierungsbedarf ermittelt, eine Bewertung durchgeführt und das Informationsmemorandum für Investoren vorbereitet.
Finanzielle Bewertung / Valuation – Ölindustrie
Für ein multinationales Energieunternehmen (Frankreich / Deutschland) hat LJ Advisory Entwicklungsszenarien erarbeitet, eine Bewertung durchgeführt und Sensitivitätsanalysen für makroökonomische Faktoren eines wichtigen industriellen Vermögenswerts vorgenommen.
Finanzielle Bewertung / Valuation – Investmentfonds
Für eine internationale Vermögensverwaltungsgruppe in der Schweiz führte LJ Advisory eine Unternehmensbewertung für einen Management-Buy-In durch.

Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest Technology
The stem cell banking market is growing due to advancements in cryopreservation, cell bank prep, monoclonal antibodies, and the rising adoption of stem cell therapy. The stem cell banking market is growing due to advancements in cryopreservation, cell bank prep, monoclonal antibodies, and the rising adoption of stem cell therapy.
Pharming announces public cash offer to the shareholders of Abliva AB
Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million
Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating serious, rare genetic diseases
Alpha Modus and Insight Acquisition Corp Close Business Combination and Alpha Modus will Begin Trading Under “AMOD” Ticker
CORNELIUS, N.C. and NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. ("Alpha Modus" or the “Company”), a technology company with a core focus on artificial intelligence in retail, is pleased to announce that the business combination between Insight Acquisition Corp. and Alpha Modus Corp. has closed, and Alpha Modus’s common stock and warrants will begin trading on the Nasdaq Global Market under the ticker symbols “AMOD” and “AMODW”, respectively, on Monday, December 16, 2024.
AleAnna, Inc. Announces Completion of Business Combination between Swiftmerge Acquisition Corp. and AleAnna Energy, LLC
AleAnna Accelerates Efforts to Improve Italy’s Energy Sustainability and Security with Strategic Business Combination AleAnna Accelerates Efforts to Improve Italy’s Energy Sustainability and Security with Strategic Business Combination
Alpha Modus Plans to Close Business Combination With Insight Acquisition Corp. Today and Expects to Begin Trading on Monday Under “AMOD” Ticker
CORNELIUS, N.C. and NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Modus Corp. ("Alpha Modus" or the “Company”), a technology company with a core focus on artificial intelligence in retail, and Insight Acquisition Corp., a special purpose acquisition company (“Insight” NASDAQ: INAQ) plan to close their business combination today. Alpha Modus expects to begin trading on the Nasdaq Global Market under the ticker symbols “AMOD” (its common stock) and “AMODW” (its warrants) on Monday, December 16, 2024.
Fairfax Announces Acquisition of OMERS Investment in Brit
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has increased its ownership interest in Brit Limited to 100% from 86.2% by acquiring the interest of OMERS, the pension plan for Ontario’s municipal employees, for cash consideration of approximately US$383 million.
Freehold Royalties Announces Closing of Strategic Midland Basin Acquisition, Credit Facility Increase and Declares Dividend for December 2024
CALGARY, Alberta, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) is pleased to announce that it has closed its previously announced transaction to acquire mineral title and royalty interests in the core of the Midland Basin in Texas (the Acquisition or the Acquired Assets) for approximately $259 million, net of estimates for exchange rate, expenses and customary closing adjustments.
Rogers fait le point sur son acquisition de la part de 37,5 % de Bell dans MLSE
TORONTO, 13 déc. 2024 (GLOBE NEWSWIRE) -- Rogers Communications (TSX : RCI. A et RCI.B) (NYSE : RCI) (« Rogers ») a annoncé aujourd’hui avoir obtenu l’aval du Bureau de la concurrence pour l’acquisition de la part de 37,5 % de Bell dans Maple Leaf Sports & Entertainment (MLSE).
Rogers Provides Update on Its Acquisition of Bell’s 37.5% Stake in MLSE
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rogers Communications (TSX: RCI.A and RCI.B) (NYSE: RCI) today announced it has received clearance from the Competition Bureau to proceed with the acquisition of Bell’s 37.5% stake in Maple Leaf Sports & Entertainment.

error: Le contenu est protégé.